Cara Therapeutics Statistics

Total Valuation

LON:0HTC has a market cap or net worth of GBP 19.25 million. The enterprise value is 24.22 million.

Market Cap	19.25M
Enterprise Value	24.22M

Important Dates

The last earnings date was Monday, May 12, 2025.

Earnings Date	May 12, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+1.12%
Shares Change (QoQ)	+0.02%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	3.90M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	3.38
PB Ratio	-5.25
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-0.43
EV / Sales	4.47
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-0.49

Financial Position

The company has a current ratio of 11.03

Current Ratio	11.03
Quick Ratio	10.67
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	-0.72
Interest Coverage	-6.58

Financial Efficiency

Return on equity (ROE) is -270.01% and return on invested capital (ROIC) is -49.77%.

Return on Equity (ROE)	-270.01%
Return on Assets (ROA)	-41.09%
Return on Invested Capital (ROIC)	-49.77%
Return on Capital Employed (ROCE)	-139.96%
Revenue Per Employee	570,082
Profits Per Employee	-5.66M
Employee Count	10
Asset Turnover	0.08
Inventory Turnover	19.56

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -81.26% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-81.26%
50-Day Moving Average	15.15
200-Day Moving Average	12.47
Relative Strength Index (RSI)	55.17
Average Volume (20 Days)	89

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	3.10

Income Statement

In the last 12 months, LON:0HTC had revenue of GBP 5.70 million and -56.61 million in losses. Loss per share was -12.41.

Revenue	5.70M
Gross Profit	-23.36M
Operating Income	-44.56M
Pretax Income	-56.92M
Net Income	-56.61M
EBITDA	-44.40M
EBIT	-44.56M
Loss Per Share	-12.41

Full Income Statement

Balance Sheet

The company has 30.28 million in cash and 35.50 million in debt, giving a net cash position of -5.23 million.

Cash & Cash Equivalents	30.28M
Total Debt	35.50M
Net Cash	-5.23M
Net Cash Per Share	n/a
Equity (Book Value)	-3.67M
Book Value Per Share	-0.80
Working Capital	31.83M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -48.66 million and capital expenditures -835,513, giving a free cash flow of -49.49 million.

Operating Cash Flow	-48.66M
Capital Expenditures	-835,513
Free Cash Flow	-49.49M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-781.57%
Pretax Margin	-998.53%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

LON:0HTC does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.12%
Shareholder Yield	-1.12%
Earnings Yield	-294.01%
FCF Yield	-257.07%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on December 31, 2024. It was a reverse split with a ratio of 0.0833333333.

Last Split Date	Dec 31, 2024
Split Type	Reverse
Split Ratio	0.0833333333

Scores

LON:0HTC has an Altman Z-Score of -26.74. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-26.74
Piotroski F-Score	n/a